Clinical Trial

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males

Name: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males — clinical trial record (NCT07407543)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of SRN001 in healthy adult volunteers.

Trial Details

NCT Number	NCT07407543
Lead Sponsor	siRNAgen Therapeutics Inc.
Conditions	Idiopathic Pulmonary Fibrosis
Enrollment	30 participants
Start Date	2026-01-05
Primary Completion	2026-10-31 (estimated)
Study Completion	2027-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-12